Matthew Bailey | Senior Scientist
Aptevo Therapeutics
Matthew Bailey is a Senior Scientist at Aptevo Therapeutics in Molecular Biology and Protein Engineering. Previously, he developed protein purification technology as a postdoctoral associate at The University of Washington and in collaboration with Proteios Technology. He received his Ph.D. in Molecular Biology at The University of Oregon. Hobbies include running, relaxing with his dog, and writing science fiction.
Appearances:
Festival of Biologics Day 2 @ 16:30
Engineering Bispecific, Target-Activated ADAPTIRs for Cancer Immunotherapy
Bispecific antibodies and antibody-like molecules can treat can direct the immune system to attack cancer cells. The ADAPTIR is a modular, bispecific antibody-like molecule for a variety of tumor-targeting mechanisms of action. In this talk, I'll highlight the power of the ADAPTIR platform to induce tumor cell killing and immune cell activation.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events